Drug ID: | NPD3354 |
Drug Name: | Indeglitazar |
Molecular Formula: | C19H19NO6S |
Canonical SMILES: | COc1ccc(cc1)S(=O)(=O)n1cc(c2c1ccc(c2)OC)CCC(=O)O |
Standard InCHI: | InChI=1S/C19H19NO6S/c1-25-14-4-7-16(8-5-14)27(23,24)20-12-13(3-10-19(21)22)17-11-15(26-2)6-9-18(17)20/h4-9,11-12H,3,10H2,1-2H3,(H,21,22) |
Standard InCHIKey: | YMPALHOKRBVHOJ-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002863 |
DrugBank | DB07724 |
ChEMBL | CHEMBL1232583 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11395145 |
ChEBI | |
CAS Number | 835619-41-5 |
Molecular Weight | 389.09 |
ALogP | -1.1827 |
MLogP | 2.67 |
XLogP | 2.623 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 10 |
TPSA | 103.21 |
RO5 Violation | 0 |